Skip to main content

Vicente Descalzo Jorro

Institutions of which they are part

Predoctoral researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Vicente Descalzo Jorro

Institutions of which they are part

Predoctoral researcher
Infectious Diseases
Vall Hebron Institut de Recerca

Projects

Pre-clinical evaluation of safety and immunogenicity of recombinant BCG expressing SIV:consv in Cynomolgus macaques. A new platform for a bivalent HIV/TB vaccine development

IP: Joan Joseph Munné
Collaborators: Vicente Descalzo Jorro
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI20/00217
Duration: 01/01/2021 - 30/06/2025

Related news

AIDAY 2026 showcased the artificial intelligence initiatives, infrastructures and projects already being developed across the Campus.

All patients showed a favorable clinical course and responded well to antibiotic treatment, without complications.

The study results show that the local presence of IL-1β promotes the development of myeloid cells with an immunosuppressive function.

Related professionals

Mireia Andres Villarreal

Mireia Andres Villarreal

Predoctoral researcher
Cardiovascular Diseases
Read more
Xavier Buxo Masip

Xavier Buxo Masip

Predoctoral researcher
Physical Medicine and Rehabilitation
Read more
Gerard Oristrell Santamaria

Gerard Oristrell Santamaria

Predoctoral researcher
Cardiovascular Diseases
Read more
Estefania De la Torre Villaescusa

Estefania De la Torre Villaescusa

Cap d'Unitat
Teaching Unit
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.